Hepatitis C Virus Genetic Diversity and Drug Mutational Analysis in Cameroon: 1992 to 2013
Judith Ndongo Torimiro, Laure Arlette Tchapda, Maurice Boda, Jude Saber Bimela, Dale Netski, Desire Takou, Donald Scot Burke, Ubald Tamoufe, Eitel Mpoudi-Ngole, Henry Namme Luma, Oudou Njoya, Wilfred Fon Mbacham, Nathan Wolfe & Stuart Ray · Microbiology Research Journal International · 2016
HCV infection is endemic in Cameroon. A Direct acting agent (DAAs), sofosbuvir that target the HCV non-structural 5B RNA-dependent RNA polymerase (NS5B RdRp) has recently been incorporated into the standard of care in Cameroon but no drug resistance study to this DAA has been rep...
Open access
Research Article
10.9734/BMRJ/2016/28823